Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Carson PE"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł :
Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.
Autorzy :
Bhatt AS; Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA.
Lindenfeld J; Cardiology Division, Vanderbilt University, Nashville, Tennessee, USA.
Bristow M; Division of Cardiology, University of Colorado, Aurora, Colorado, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Felker GM; Duke Clinical Research Institute and Division of Cardiology, Duke University, Durham, North Carolina, USA.
Fonarow GC; Department of Internal Medicine, University of California-Los Angeles, Los Angeles, California, USA.
Greene SJ; Duke Clinical Research Institute and Division of Cardiology, Duke University, Durham, North Carolina, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia.
Solomon SD; Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California, USA.
Vaduganathan M; Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Wittes J; Statistics Collaborative, Washington, DC, USA.
Fiuzat M; Duke Clinical Research Institute and Division of Cardiology, Duke University, Durham, North Carolina, USA.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2021 Jan; Vol. 9 (1), pp. 1-12. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2.
Autorzy :
Loungani RS; Division of Cardiology and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, California, USA.
Metra M; Cardiology, ASST Civil Hospitals, and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Allen LA; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Chen CW; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Cotter G; Momentum Research, Durham, North Carolina, USA.
Davison BA; Momentum Research, Durham, North Carolina, USA.
Eapen ZJ; Anthem Incorporated, Indianapolis, Indiana, USA.
Filippatos GS; School of Medicine, University of Cyprus, Nicosia, Cyprus, Greece; Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Gimpelewicz C; Novartis Pharma AG, Basel, Switzerland.
Greenberg B; University of California San Diego Health, Cardiovascular Institute, La Jolla, California, USA.
Holbro T; Novartis Pharma AG, Basel, Switzerland.
Januzzi JL Jr; Division of Cardiology, Department of Medicine, Harvard Medical School, and Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, Massachusetts, USA.
Lanfear DE; Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Pang PS; Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Piña IL; Division of Cardiology, Wayne State University, Detroit, Michigan, USA.
Ponikowski P; Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.
Miller AB; Department of Cardiology, University of Florida, Jacksonville, Florida, USA.
Voors AA; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
Felker GM; Division of Cardiology and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2020 Dec; Vol. 8 (12), pp. 999-1008. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA. Electronic address: .
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, USA.
Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ambardekar AV; Division of Cardiology, University of Colorado, Aurora, Colorado, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Jacob R; Patient Representative, Dublin, Ohio, USA.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, Massachusetts, USA.
Konstam MA; The CardioVascular Center of Tufts Medical Center, Boston, Massachusetts, USA.
Krucoff MW; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, California, USA.
Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stockbridge N; United States Food and Drug Administration, Silver Spring, Maryland, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California, USA.
Unger EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Zeitler EP; Dartmouth-Hitchcock Medical Center and The Dartmouth Institute, Lebanon, New Hampshire, USA.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia, USA; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2020 Dec; Vol. 8 (12), pp. 961-972. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.
Autorzy :
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: .
Fiuzat M; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Kao DP; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
Cerkvenik J; Medtronic Inc., Minneapolis, Minnesota.
Schaber DE; Medtronic Inc., Minneapolis, Minnesota.
Verta P; Edwards Lifesciences, Irvine, California.
Kazmierski RT; U.S. Food and Drug Administration, Silver Spring, Maryland.
Shinnar M; U.S. Food and Drug Administration, Silver Spring, Maryland.
Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland.
Unger EF; U.S. Food and Drug Administration, Silver Spring, Maryland.
Zuckerman B; U.S. Food and Drug Administration, Silver Spring, Maryland.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi.
Felker GM; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Konstam MA; CardioVascular Center of Tufts Medical Center, Boston, Massachusetts.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
Abraham WT; Departments of Medicine, Physiology, and Cell Biology, Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2019 Nov; Vol. 7 (11), pp. 913-921. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
Forms as Topic*
Medical Records*
Heart Failure/*diagnosis
Heart Failure/*therapy
Humans
Czasopismo naukowe
Tytuł :
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Autorzy :
Shen L; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Anand IS; Department of Medicine, University of Minnesota Medical School, and Veterans Affairs Medical Center, Minneapolis, Minnesota.
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Desai AS; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Granger CB; Division of Cardiovascular Medicine, Department of Internal Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Department of Medicine, Western University, London, Ontario, Canada.
Pfeffer MA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Solomon SD; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Zile MR; Medical University of South Carolina, Charleston, South Carolina; Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina.
McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2019 May; Vol. 7 (5), pp. 418-427. Date of Electronic Publication: 2019 Apr 10.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiac Pacing, Artificial/*statistics & numerical data
Heart Failure/*physiopathology
Hospitalization/*statistics & numerical data
Pacemaker, Artificial/*statistics & numerical data
Ventricular Dysfunction, Left/*physiopathology
Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Benzimidazoles/therapeutic use ; Cardiovascular Diseases/mortality ; Cause of Death ; Death, Sudden, Cardiac/epidemiology ; Female ; Heart Failure/drug therapy ; Humans ; Irbesartan/therapeutic use ; Male ; Middle Aged ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Mortality ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Spironolactone/therapeutic use ; Stroke Volume ; Tetrazoles/therapeutic use
Czasopismo naukowe
Tytuł :
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio. Electronic address: .
Kuck KH; Department of Cardiology, ASKLEPIOS Klinik St. Georg, Hamburg, Germany.
Goldsmith RL; Exercise Physiology Laboratory, Columbia University Medical Center, New York, New York.
Lindenfeld J; Department of Heart Failure and Transplant, Vanderbilt Heart, Nashville, Tennessee.
Reddy VY; Department of Cardiac Arrhythmia Services, The Mount Sinai Hospital, New York, New York.
Carson PE; Medical Intensive Care Unit, Washington VA Medical Center, Washington, DC.
Mann DL; Cardiovascular Division, Medicine, Washington University School of Medicine, St. Louis, Missouri.
Saville B; Berry Consultants, Austin, Texas.
Parise H; R. P. Chiacchierini Consulting, Gaithersburg, Maryland.
Chan R; Chan Heart Rhythm Institute, Mesa, Arizona.
Wiegn P; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, Dallas, Texas.
Hastings JL; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, Dallas, Texas.
Kaplan AJ; Department of Clinical Cardiac Electrophysiology, Cardiovascular Associates of Mesa, Mesa, Arizona.
Edelmann F; Department of Cardiology and Pneumology, Universität Göttingen, Göttingen, Germany.
Luthje L; Department of Cardiology and Pneumology, Universität Göttingen, Göttingen, Germany.
Kahwash R; Department of Heart Failure & Transplantation, The Ohio State University Heart and Vascular Center, Columbus, Ohio.
Tomassoni GF; Department of Clinical Cardiac Electrophysiology, Baptist Health Lexington, Lexington, Kentucky.
Gutterman DD; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Stagg A; Clinical Trials, Impulse Dynamics, Orangeburg, New York.
Burkhoff D; Cardiovascular Research Foundation, New York, New York.
Hasenfuß G; Heart Center of Göttingen, University Medical Center Göttingen, Göttingen, Germany.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2018 Oct; Vol. 6 (10), pp. 874-883. Date of Electronic Publication: 2018 May 10.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Myocardial Contraction*
Electric Stimulation/*methods
Heart Failure/*therapy
Electric Stimulation/adverse effects ; Electric Stimulation/instrumentation ; Electrodes, Implanted ; Exercise Test ; Exercise Tolerance ; Female ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Quality of Life ; Stroke Volume/physiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Trying to Make Progress on Survival in a Complicated Area: Sudden Death in HFpEF.
Autorzy :
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2018 Aug; Vol. 6 (8), pp. 662-664. Date of Electronic Publication: 2018 Jun 06.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Heart Failure*
Death, Sudden, Cardiac ; Humans ; Stroke Volume ; Ventricular Function, Left
Opinia redakcyjna
Tytuł :
Redefining "Winning" and Its Implications in Heart Failure Clinical Trials.
Autorzy :
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2017 Aug; Vol. 5 (8), pp. 600-602.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Emergency Service, Hospital*
Heart Failure*
Hospitalization ; Humans ; Physical Examination
Opinia redakcyjna
Tytuł :
Natriuretic Peptide Levels and Interaction With Treatment in HFpEF: Intriguing Findings in a "House of Cards"?
Autorzy :
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2017 Apr; Vol. 5 (4), pp. 253-255.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Heart Failure*
Natriuretic Peptides*
Biomarkers ; Humans ; Natriuretic Peptide, Brain ; Stroke Volume
Opinia redakcyjna
Tytuł :
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Autorzy :
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom; Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Køber L; Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
McKelvie RS; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Zile MR; Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina.
Anand IS; Division of Cardiology, University of Minnesota, Minneapolis, Minnesota.
Komajda M; Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France.
Cleland JGF; Harefield Hospital, Imperial College, London, United Kingdom.
Carson PE; Washington DC Veterans Affairs Medical Center and Georgetown University, Washington, DC.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2015 Jun; Vol. 3 (6), pp. 478-486.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Failure/*blood
Hospitalization/*statistics & numerical data
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
Stroke Volume/*physiology
Aged ; Female ; Heart Failure/epidemiology ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Male ; Predictive Value of Tests ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
Tytuł :
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Autorzy :
Carson PE; Washington Veterans Affairs Medical Center and Georgetown University, Washington, District of Columbia. Electronic address: peter.carson@med.va.gov.
Anand IS; Veterans Affairs Health Care System and University of Minnesota, Minneapolis, Minnesota.
Win S; Veterans Affairs Health Care System and University of Minnesota, Minneapolis, Minnesota.
Rector T; Veterans Affairs Health Care System and University of Minnesota, Minneapolis, Minnesota.
Haass M; Theresienkrankenhaus, Mannheim, Germany.
Lopez-Sendon J; Hospital Gregorio Maranon, Madrid, Spain.
Miller A; University of Florida-Jacksonville, Jacksonville, Florida.
Teerlink JR; San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California.
White M; Montreal Heart Institute Research Center, Montreal, Quebec, Canada.
McKelvie RS; Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.
Komajda M; Université Paris, Pitie Salpetriere Hospital, Paris, France.
Zile MR; Ralph H. Johnson Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina.
McMurray JJ; British Heart Foundation Glasgow Cardiovascular Research Center, Glasgow, United Kingdom.
Massie B; San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2015 Jun; Vol. 3 (6), pp. 429-441. Date of Electronic Publication: 2015 May 14.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Stroke Volume*/physiology
Heart Failure/*mortality
Hospitalization/*statistics & numerical data
Aged ; Female ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Male ; Prognosis ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies